Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Effectiveness of human albumin solution in the treatment of patients with cirrhosis

ayse nuransoy cengiz, yasir furkan cagin, YUKSEL SECKIN, melih KARINCAOGLU.




Abstract
Cited by 0 Articles

Objectives: Human serum albumin is synthesized in the liver and is the main plasma protein responsible for plasma oncotic pressure. Studies on the use of Human albumin solution (HAS) in patients with cirrhosis, for prevention of cirrhosis complications or for treatment are ongoing. The beneficial role of albumin beyond volume expansion is an evolving field, and further research is needed to understand the role of albumin in modulating biological functions and disease processes, particularly in liver disease and sepsis, but also in other diseases with albumin dysfunction.

Materials and methods: We investigated the effectiveness of HAS through the patients with cirrhosis who received 3 consecutive days (2x1 per day) 190-210 g / L protein were retrospectively analyzed.

Results: Albumin infusion was found to be beneficial for serum albumin levels in the patient with high Child-Pugh scores.

Conclusions: The complications of cirrhosis can be reduced, particularly in patients awaiting transplantation, by support with HAS treatment.

Key words: Cirrhosis; albumin treatment; liver transplant; ascites.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.